Orthofix Medical (OFIX) Price to Sales (2010 - 2026)

Orthofix Medical (OFIX) has reported Price to Sales for 17 consecutive years, with 1.76 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 18.57% year-over-year to 1.76; the trailing twelve-month figure through Jun 2026 stood at 0.45 (down 17.89% YoY), and the FY2025 full-year result was 0.73, down 12.63% from the prior year.
• Price to Sales was 1.76 for Q2 2026 at Orthofix Medical, down from 2.35 in the prior quarter.
• The five-year high for Price to Sales was 6.1 in Q1 2022, with the low at 1.76 in Q2 2026.
• Historically, Price to Sales has averaged 3.09 across 5 years, with a median of 2.96 in 2024.
• Annual changes were most pronounced in 2022 — Price to Sales sank 49.89% — and 2024, when it rose 24.65%.
• Tracing OFIX's Price to Sales over 5 years: stood at 3.39 in 2022, then retreated by 26.18% to 2.5 in 2023, then increased by 24.65% to 3.12 in 2024, then dropped by 11.87% to 2.75 in 2025, then slumped by 35.73% to 1.76 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 1.76 in Q2 2026, 2.35 in Q1 2026, and 2.75 in Q4 2025.